A Comparison of Two Brief Suicide prevention Interventions Tailored for Youth on the Autism Spectrum
This study is by invitation only.
Multiple locations, including Baltimore
Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is by invitation only.
Multiple locations, including BaltimoreCDR Versus MATRICS Cognitive Batteries in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In BostonA randomised controlled trial comparing Internet based cognitive behavioural therapy for major depressive disorder plus a cognitive bias modification intervention (OxIGen) version A vs. Internet based cognitive behavioural therapy for major depressive disorder plus a cognitive bias modification intervention (OxIGen) version B on symptoms of depression and negative interpretation bias.
This study has finished and is no longer accepting participants.
In AustraliaRandomized Comparison of Monotherapy (Risperidone, Quetiapine, or Olanzapine) Versus Combination Therapy (Risperidone, Quetiapine, or Olanzapine + Divalproex)in the Management of Dementia With Agitation: A Pilot Comparison of Two Standard Therapies
This study has finished and is no longer accepting participants.
In AtlantaA Comparison of Two Ultra-brief Interventions in Primary Care for Patients With Anxiety, Depression, and Stress.
Read the official source — NCT05946382A Comparison of Two Ultra-brief Interventions in Primary Care for Patients With Anxiety, Depression, and Stress: a Pilot Randomized Controlled Trial.
This study has finished and is no longer accepting participants.
In HelsingborgThis study has finished and is no longer accepting participants.
Multiple locations, including AtlantaThe NEURAPRO-E Study: A multicenter Randomized Controlled Trial (RCT) of Omega-3 Fatty Acids and Cognitive-Behavioural Case Management for Symptomatic Patients at Ultra-High Risk for Early Progression to Schizophrenia and Other Psychotic Disorders to Assess the 6-month Transition Rate to First Episode Psychosis.
This study has finished and is no longer accepting participants.
In AustraliaA Phase 3, Multicenter, Double-Blind Comparison of LY2140023 and Aripiprazole in Patients With DSM-IV-TR Schizophrenia Followed by Open-Label Treatment With LY2140023
This study ended early.
Multiple locations, including CerritosThe NEURAPRO-Q (North America, EURope, Australia PROdrome) Study: A multicentre randomised controlled trial (RCT) to evaluate the effect of Quetiapine and Cognitive-Behavioural Case Management on the incidence of first episode psychosis in Symptomatic Patients at Ultra-High Risk for Early Progression to Schizophrenia and Other Psychotic Disorders
This study ended early.
In ChinaTreatment of Patients With Concurrent Eating Disorder and Personality Disorder: A Controlled Randomized Comparison Study, of Treatments Given to In-patients and Out-patients.
This study has finished and is no longer accepting participants.
In TrondheimThis study was withdrawn before enrollment.
In BaltimoreCARE-MI: A Comprehensive Group Intervention for Psychosocial Personnel at Risk of Experiencing Symptoms of Post-traumatic Stress and/or Moral Injury Associated With Work-related Stress: Design, Implementation, and Efficacy
This study has finished and is no longer accepting participants.
In MadridWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.